XLO Xilio Therapeutics, Inc.

NASDAQ
$9.17

Xilio Therapeutics, Inc. (XLO) is expected to report earnings on November 11, 2026, before the market open.

Xilio Therapeutics Reported Earnings
Wednesday, August 12, 2026 · 7:30 AM ET
Earnings Date
Nov 11
Wednesday · 7:30 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Xilio Therapeutics, Inc.

Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.

Sector

Healthcare

Industry

Biotechnology